<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/37457?offset=480</link>
	<atom:link href="https://bioinformaticsonline.com/related/37457?offset=480" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	
<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/researchlabs/view/39827/prof-dr-med-andreas-ramming</guid>
  <pubDate>Wed, 07 Aug 2019 03:25:48 -0500</pubDate>
  <link></link>
  <title><![CDATA[Prof. Dr. med. Andreas Ramming]]></title>
  <description><![CDATA[
<p>In many autoimmune diseases, a misdirected immune response leads to chronic inflammation and subsequently to fibrotic and degenerative tissue remodeling. Therapeutic options are available for inflammatory joint diseases, but only about 40% of patients respond to these existing therapies on a permanent basis. In the remaining cases, these therapies miss their target from the beginning or later during the course of treatment failure. There are currently no causal therapies available for the treatment of fibrotic autoimmune diseases such as systemic sclerosis. Therefore, there is an urgent need to develop new therapeutic options for the treatment of fibrotic and synovitic autoimmune diseases. His group is therefore deal with the molecular mechanisms of these misdirected signaling pathways for the development of novel, targeted therapies</p>

<p>http://www.medizin3.uk-erlangen.de/forschung/arbeitsgruppen/matrixbiologie-entzuendliche-signalwege-in-arthritis-und-fibrose/</p>
]]></description>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/41039/phd-position-in-translational-medicine</guid>
  <pubDate>Sat, 15 Feb 2020 06:07:19 -0600</pubDate>
  <link></link>
  <title><![CDATA[PhD position in Translational Medicine]]></title>
  <description><![CDATA[
<p>https://www.jobvector.de/jobs-stellenangebote/biologie-life-sciences/wissenschaftliche-r-mitarbeiter-in/phd-position-translational-medicine-129981.html?suid=1b510358c7578e8f75cf04a464fc21a404a574ca</p>

<p>Essential experience / qualifications:<br />Master / Diploma in Biology, Biochemistry, Molecular Medicine or similar; solid knowledge of molecular and cell biological techniques; good English knowledge</p>

<p>Applications:<br />Please send your application (including CV, letter of motivation, contact information of two references, and list of publication) by 13.03.2020 at the latest to:</p>

<p>Universitätsklinikum Erlangen<br />Chirurgische Klinik<br />Translational Research Center<br />Prof. Dr. rer. nat. Michael Stürzl<br />Schwabachanlage 12<br />91054 Erlangen<br />E-Mail: michael.stuerzl@uk-erlangen.de</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/42485/fastprongs-fast-preprocessing-of-next-generation-sequencing-reads</guid>
	<pubDate>Sat, 26 Dec 2020 08:35:21 -0600</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/42485/fastprongs-fast-preprocessing-of-next-generation-sequencing-reads</link>
	<title><![CDATA[FastProNGS: fast preprocessing of next-generation sequencing reads]]></title>
	<description><![CDATA[<p><span>FastProNGS to integrate the quality control process with automatic adapter removal. Parallel processing was implemented to speed up the process by allocating multiple threads. Compared with similar up-to-date preprocessing tools, FastProNGS is by far the fastest.&nbsp;</span></p><p>Address of the bookmark: <a href="https://github.com/Megagenomics/FastProNGS" rel="nofollow">https://github.com/Megagenomics/FastProNGS</a></p>]]></description>
	<dc:creator>Rahul Nayak</dc:creator>
</item>

</channel>
</rss>